Babak Jalilian

Dr. Babak Jalilian


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2016 in Molecular and Cellular Therapies
Verified
Journal Article
Open access
PDF file
RBRikke Bech
Rikke Bech
BJBabak Jalilian
Babak Jalilian
RARalf Agger
Ralf Agger
LILars Iversen
Lars Iversen
MEMogens Erlandsen
Mogens Erlandsen
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
Psoriasis is an inflammatory disease characterized by leukocyte skin infiltration. Interestingly, recent works suggest that the migration of dendritic cells (DCs) is abnormal in psoriatic skin. DCs have significant role in regulating the function of T lymphocytes, at least in part influenced by the local environment of cytokines. In psoriatic skin lesions the expression of IL-20 is highly up-regulated. It is unclear if this cytokine has any influence on DCs.

Verified
Journal Article
Open access
PDF file
BJBabak Jalilian
Babak Jalilian
HEHalldór Bjarki Einarsson
Halldór Bjarki Einarsson
TVThomas Vorup-Jensen
Thomas Vorup-Jensen
Multiple sclerosis is a disease of the central nervous system, resulting in the demyelination of neurons, causing mild to severe symptoms. Several anti-inflammatory treatments now play a significant role in ameliorating the disease. Glatiramer acetate (GA) is a formulation of random polypeptide copolymers for the treatment of relapsing-remitting MS by limiting the frequency of attacks. While evidence suggests the influence of GA on inflammatory responses, the targeted molecular mechanisms remain poorly understood. Here, we review the multiple pharmacological modes-of-actions of glatiramer acetate in treatment of multiple sclerosis. We discuss in particular a newly discovered interaction between the leukocyte-expressed integrin αMβ2 (also called Mac-1, complement receptor 3, or CD11b/CD18) and perspectives on the GA co-polymers as an influence on the function of the innate immune system.

4 February 2014 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
TKTue W Kragstrup
Tue W Kragstrup
BJBabak Jalilian
Babak Jalilian
MHMalene Hvid
Malene Hvid
AKAnders Kjærgaard
Anders Kjærgaard
RØRené Østgård
René Østgård
BDBent Deleuran
Bent Deleuran
Introduction: Spondyloarthritis (SpA) comprises a group of diseases often associated with HLA-B27 and characterized by inflammation of the entheses and joints of the axial skeleton. The inflammatory process in SpA is presumably driven by innate immune cells but is still poorly understood. Thus, new tools for monitoring and treating inflammation are needed. The family of CD18 integrins is pivotal in guiding leukocytes to sites of inflammation, and CD18 hypomorphic mice develop a disease resembling SpA. Previously, we demonstrated that altered soluble CD18 (sCD18) complexes in the blood and synovial fluid of patients with arthritis have anti-inflammatory functions. Here, we study the mechanisms for these alterations and their association with SpA disease activity. Methods: Plasma levels of sCD18 in a study population with 84 patients with SpA and matched healthy controls were analyzed with a time-resolved immunoflourometric assay (TRIFMA). Binding of sCD18 to endothelial cells and fibroblast-like synoviocytes (FLSs) was studied with confocal microscopy. Shedding of CD18 from peripheral blood mononuclear cells (PBMCs) was studied with flow cytometry and TRIFMA. Results: Plasma levels of sCD18 were decreased in patients with SpA compared with healthy volunteers (P <0.001), and the lowest levels were in the HLA-B27-positive subgroup (P <0.05). In a multiple regression model, the sCD18 levels exhibited an inverse correlation with the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (P <0.05), the level of morning stiffness (P <0.05), the Bath Ankylosing Spondilitis Metrology Index (P <0.05), the physician global assessment score (P <0.01), and the sacroiliac magnetic resonance imaging activity score (P <0.05). The mechanisms for these changes could be simulated in vitro. First, sCD18 in plasma adhered to inflammation-induced intercellular adhesion molecule 1 (ICAM-1) on endothelial cells and FLS, indicating increased consumption. Second, CD18 shedding from SpA PBMCs correlated inversely with the BASDAI (P <0.05), suggesting insufficient generation. CD18 was shed primarily from intermediate CD14++ CD16+ monocytes, supporting the view that alterations in innate immunity can regulate the inflammatory processes in SpA. Conclusions: Taken together, the failure of patients with SpA to maintain adequate sCD18 levels may reflect insufficient CD18 shedding from monocytes to counterbalance the capture of sCD18 complexes to inflammation-induced ICAM-1. This could increase the availability of ICAM-1 molecules on the endothelium and in the synovium, facilitating leukocyte migration to the entheses and joints and aggregating disease activity.

1 March 2017 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
SCStig Hill Christiansen
Stig Hill Christiansen
XZXianwei Zhang
Xianwei Zhang
KJKristian Juul-Madsen
Kristian Juul-Madsen
MHMichael Lykke Hvam
Michael Lykke Hvam
BVBrian Stougaard Vad
Brian Stougaard Vad
TVThomas Vorup-Jensen
Thomas Vorup-Jensen

1 January 2010 in Acta Virologica
Verified
Journal Article
Closed access
MRM. Rasoli
M. Rasoli
AOA. Omar
A. Omar
IAI. Aini
I. Aini
BJBabak Jalilian
Babak Jalilian
SSS. Syed_Hassan
S. Syed_Hassan
MMM. Mohamed
M. Mohamed
Fusion of HSP70 gene of Mycobacterium tuberculosis to hemagglutinin (H5) gene of avian influenza virus in DNA vaccine enhances its potency

24 May 2010 in Genetic Vaccines and Therapy
Verified
Journal Article
Open access
PDF file
BJBabak Jalilian
Babak Jalilian
AOAbdul Omar
Abdul Omar
MBMohd Hair Bejo
Mohd Hair Bejo
NANoorjahan Alitheen
Noorjahan Alitheen
MMehdi Rasoli Pirozyan
Mehdi Rasoli Pirozyan
SMSohkichi Matsumoto
Sohkichi Matsumoto
Background: Studies have shown that DNA vaccines can induce protective immunity, which demonstrated the high potential of DNA vaccines as an alternative to inactivated vaccines. Vaccines are frequently formulated with adjuvants to improve their release, delivery and presentation to the host immune system.Methods: The H5 gene of H5N1 virus (A/Ck/Malaysia/5858/04) was cloned separately into pcDNA3.1 + vector. The immunogenicity of the cloned H5 DNA vaccine was tested on SPF chickens using two different approaches. First approach was using H5 DNA vaccine (pcDNA3.1/H5) and the second was using H5 DNA vaccine in addition to the pcDNA3.1/MDP1 vaccine. Ten days old chickens inoculated three times with two weeks intervals. The spleen and muscle samples from chickens immunized with H5 (pcDNA3.1/H5) and H5 + MDP1 (pcDNA3.1/H5 + pcDNA3.1/MDP1) vaccines were collected after sacrificing the chickens and successfully expressed H5 and MDP1 RNA transcripts. The sera of immunized chickens were collected prior to first immunization and every week after immunization; and analyzed using enzyme-linked immunosorbent assay (ELISA) and hemagglutination inhibition (HI) test.Results: Results of competitive ELISA showed successful antibody responses two weeks post immunization. The HI test showed an increased in antibody titers during the course of experiment in group immunized with H5 and H5 + MDP1 vaccines. The result showed that the constructed DNA vaccines were able to produce detectable antibody titer in which the group immunized with H5 + MDP1 vaccine produced higher antibody comparing to H5 vaccine alone.Conclusions: This study shows for the first time the usefulness of MDP1 as a genetic adjuvant for H5 DNA vaccine.